Lexicon Pharmaceuticals
LXRX
#7493
Rank
A$0.60 B
Marketcap
A$1.67
Share price
-19.44%
Change (1 day)
34.67%
Change (1 year)

Earnings for Lexicon Pharmaceuticals (LXRX)

Earnings in 2025 (TTM): -A$0.11 Billion

According to Lexicon Pharmaceuticals 's latest financial reports the company's current earnings are A$70.86 Million. In 2024 the company made an earning of -A$0.29 Billion a decrease over its 2023 earnings that were of -A$0.26 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lexicon Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.11 Billion-62.06%
2024 -A$0.29 Billion13.15%
2023 -A$0.26 Billion73.74%
2022 -A$0.15 Billion16.16%
2021 -A$0.13 Billion49.82%
2020 -A$84.12 Million-147.19%
2019 A$0.17 B-203.42%
2018 -A$0.18 Billion-15.31%
2017 -A$0.21 Billion0.2%
2016 -A$0.21 Billion2920.7%
2015 -A$6.73 Million-95.33%
2014 -A$0.15 Billion-3.61%
2013 -A$0.15 Billion-5.52%
2012 -A$0.16 Billion-4.17%
2011 -A$0.17 Billion15.5%
2010 -A$0.15 Billion8.36%
2009 -A$0.14 Billion-4.81%
2008 -A$0.14 Billion28.79%
2007 -A$0.11 Billion35.71%
2006 -A$79.32 Million52.91%
2005 -A$51.87 Million-23.89%
2004 -A$68.15 Million-24.19%
2003 -A$89.89 Million-0.48%
2002 -A$90.32 Million44.12%
2001 -A$62.67 Million23.01%
2000 -A$50.95 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Thermo Fisher Scientific
TMO
A$10.18 B-10,447.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$1.42 B-1,550.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$7.38 B-7,602.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-A$0.75 Billion 656.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$95.91 M-197.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-A$39.41 Million-59.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-A$33.38 Million-66.11%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.97 B-1,090.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-A$13.63 Million-86.16%๐Ÿ‡บ๐Ÿ‡ธ USA